Unlocking Vascular Solutions: Peripheral Angioplasty Market Gears for US$ 7.2 Billion by 2033

The peripheral angioplasty market is projected to be valued US$ 3.4 billion in 2023. It is anticipated that the market will grow at a 7.7% CAGR to reach US$ 7.2 billion by 2033. Peripheral arterial disease (PAD) is characterised by the constriction or blockage of blood vessels in the peripheral arteries, typically in the legs. Peripheral angioplasty is a minimally invasive treatment for PAD. During the procedure, a catheter with a tiny balloon at the tip is put into the problematic artery. By expanding or clearing the artery, the balloon's inflation enhances blood flow. Peripheral angioplasty has seen a surge in demand recently due to several factors, such as an increase in PAD prevalence, technological advancements, as well as an increasing demand for less invasive treatments.

Peripheral artery disease affects a significant portion of the global population, especially elderly individuals and those with risk factors such as smoking, diabetes, and hypertension. The increasing prevalence of PAD is driving the demand for peripheral angioplasty procedures. The development of innovative devices and techniques has significantly improved the outcomes of peripheral angioplasty procedures. Advancements include the introduction of drug-coated balloons and drug-eluting stents, which help prevent restenosis (re-narrowing of the artery) and enhance long-term results.

Maximize Your Potential - Request Your Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-17632

The peripheral angioplasty market is also competitive, with several established and emerging players offering a range of devices and technologies. Intense competition may influence sales figures as companies strive to gain market share through product differentiation, pricing strategies, and marketing efforts.

Key Takeaways:

The peripheral angioplasty industry in the United States is predicted to reach US$ 2.3 billion by 2033, increasing at a 6.8% CAGR.
The peripheral angioplasty industry in the United Kingdom is estimated to reach a market share of US$ 229.3 million, expanding at a CAGR of 4.2% by 2033.
During the forecast period, the peripheral angioplasty industry in China is expected to reach a market share of US$ 732.1 million, securing an 13.0% CAGR.
The peripheral angioplasty industry in Japan is predicted to reach US$ 448.8 million by 2033, increasing at a 9.0% CAGR.
South Korea's peripheral angioplasty industry is predicted to achieve a market share of US$ 143.7 million, rising at an 8.7% CAGR during the forecast period.
With a CAGR of 5.2% from 2023 to 2033, the balloon catheters segment is expected to dominate the peripheral angioplasty industry.
With a CAGR of 6.3% from 2023 to 2033, the hospital is expected to dominate the peripheral angioplasty industry.

How Does the Competition Look in the Peripheral Angioplasty Market?

The peripheral angioplasty sector is a very competitive one, with many firms fighting for market share. Several significant participants in this industry comprise Boston Scientific Corporation, Medtronic, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, Cook Medical, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Becton, Dickinson and Company, MicroPort Scientific Corporation, Teleflex Incorporated, W. L. Gore & Associates, "Biotronik SE & Co. KG", AngioDynamics, Inc.

The main corporations are investing extensively in research and development efforts to develop inventive and creative products with improved reliability, efficacy, and cost.

Tactical alliances and partnerships with other companies are becoming more common in the industry, allowing parties to leverage one another's strengths and expand their market influence.

Leading firms use consolidation and mergers to strengthen their market position and gain entry into new markets. The sector is expanding significantly in developing economies, particularly in India and China.

To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites. They are also concentrating on offering cost-effective solutions to customers in these markets in order to get a competitive advantage.

Key Players:

Boston Scientific Corporation

Medtronic
Abbott Laboratories
Terumo Corporation
Johnson & Johnson
Cook Medical
B. Braun Melsungen AG
Edwards Lifesciences Corporation
Becton, Dickinson and Company
MicroPort Scientific Corporation
Teleflex Incorporated
W. L. Gore & Associates
Biotronik SE & Co. KG
AngioDynamics, Inc.

Key Developments:

In May 2022, The IN. PACTTM paclitaxel-coated percutaneous transluminal angioplasty The Balloon Catheter, has been granted approval by the USA Food and Drug Administration (FDA), Medtronic announced.

Segmentation Analysis of the Peripheral Angioplasty Market

By Product: